Scilex Holding (SCLX) Research & Development (2022 - 2026)

Scilex Holding (SCLX) has reported Research & Development for 5 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development rose 30.7% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $21.5 million (up 138.78% YoY), while the FY2025 annual figure was $20.7 million, up 114.81% from the prior year.
• Research & Development came in at $3.2 million for Q1 2026 at Scilex Holding, down from $8.2 million in the prior quarter.
• The five-year high for Research & Development was $8.2 million in Q4 2025, with the low at $1.2 million in Q3 2022.
• Average Research & Development over 5 years is $3.3 million, with a median of $2.7 million recorded in 2023.
• Across the five-year window, Research & Development plunged 42.31% in 2024 and jumped 274.68% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.6 million in 2022, then gained by 5.28% to $2.7 million in 2023, then retreated by 20.26% to $2.2 million in 2024, then surged by 274.68% to $8.2 million in 2025, then slumped by 60.7% to $3.2 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $3.2 million, $8.2 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.